Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

The woman delivered a healthy baby boy despite taking spironolactone during pregnancy.

Paternal drug exposure can harm fertility, pregnancy outcomes, and offspring health, with specific drugs linked to various reproductive issues.

Dental amalgam releases harmful mercury, posing health risks, and should be replaced with safer materials.

Dental amalgam releases harmful mercury, posing health risks, and should be replaced with safer materials.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The document concludes that managing PCOS involves lifestyle changes, medication, and monitoring for associated health risks.

Obesity greatly affects polycystic ovarian syndrome, and losing weight should be the first treatment for obese patients to improve their chances of ovulation and pregnancy.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Certain elements in maternal hair are linked to higher gestational diabetes risk and lower infant mental development.

A certain mutation in the fetal alpha 5-reductase gene is linked to a higher risk of late miscarriage.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Strainful life events may significantly trigger alopecia areata.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

Some African American women's central scalp hair loss is linked to genetics and past fungal scalp infections, with more research needed on other causes.

Taking calcium may help elderly with osteoporosis, birth control with levonorgestrel doesn't increase heart attack risk, Salmonella can cause arthritis, a national ethics committee is recommended, and sulfasalazine might help with a hair loss condition.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Adolescent females with PCOS have higher serum cystatin C levels, indicating potential metabolic and cardiovascular issues.

Most skin changes during pregnancy are harmless and moles don't significantly change, but many women experience pigmentation changes due to hormones and sun exposure.

Turkish pregnant women commonly experienced skin issues like itching and acne, and doctors mainly used topical treatments due to safety concerns during pregnancy.

Pregnancy can cause skin changes and issues that need careful management.

Reduced sexual drive may be linked to male breast cancer, while anti-estrogenic factors might lower the risk.